What is causing the tinnitus in a patient who recently started bupropion (Wellbutrin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bupropion-Induced Tinnitus

The tinnitus is most likely caused by bupropion (Wellbutrin) itself, as tinnitus is a well-documented adverse effect of this medication, occurring in 2-6% of patients in clinical trials, with higher rates at increased doses.

Evidence from FDA Drug Labeling

The FDA-approved drug label for Wellbutrin explicitly lists tinnitus as a common adverse reaction 1:

  • At 300 mg/day: Tinnitus occurred in 6% of patients vs. 2% with placebo
  • At 400 mg/day: Tinnitus occurred in 6% of patients vs. 2% with placebo
  • In Seasonal Affective Disorder trials: Tinnitus occurred in 3% of patients vs. <1% with placebo

This represents a 3-fold increase in tinnitus risk compared to placebo, establishing a clear dose-dependent relationship.

Clinical Characteristics of Bupropion-Induced Tinnitus

Based on the most recent case report 2, bupropion-induced tinnitus typically presents as:

  • Bilateral low-pitched humming or ringing
  • Onset after dose escalation (commonly when increasing from 150 mg to 300 mg daily)
  • Reversible: Partial improvement with dose reduction, complete resolution after discontinuation
  • No alternative causes: Normal audiometry, physical examination, and neuroimaging

The temporal relationship between dose escalation and symptom onset, combined with resolution after drug cessation, strongly supports causality 2.

Proposed Mechanism

The exact mechanism remains uncertain but likely involves altered dopaminergic or noradrenergic signaling within the auditory system 2. Bupropion is a norepinephrine-dopamine reuptake inhibitor, and these neurotransmitter systems play roles in auditory processing and tinnitus perception.

Clinical Management Algorithm

Immediate action:

  1. Confirm temporal relationship: Document when tinnitus started relative to bupropion initiation or dose increase
  2. Rule out other causes: Check for concurrent ototoxic medications, noise exposure, ear pathology, or hearing loss 3
  3. Assess severity and impact: Inquire about effects on sleep, concentration, and quality of life 3

Treatment approach:

  • First step: Reduce bupropion dose to previous level where tinnitus was absent 2
  • If partial improvement: Monitor for 1-2 weeks; may continue at lower dose if depression adequately controlled
  • If no improvement or severe: Discontinue bupropion and switch to alternative antidepressant 2
  • Alternative agents: Consider SSRIs (sertraline, escitalopram) which have lower tinnitus risk and may actually benefit some tinnitus patients 4, 5

Important Caveats

Do NOT:

  • Continue escalating the dose hoping tinnitus will resolve—it typically worsens with higher doses 1
  • Prescribe additional medications specifically to treat the tinnitus while continuing bupropion at the causative dose 6
  • Order extensive neuroimaging unless other concerning neurological symptoms are present 6

Critical safety consideration: If the patient has significant depression or anxiety alongside tinnitus, assess for suicidal ideation, as suicide has been reported in patients with tinnitus and coexisting psychiatric illness 3. This requires prompt intervention regardless of the tinnitus etiology.

Prognosis

The tinnitus is completely reversible in most cases once bupropion is discontinued 2. Recovery may take days to weeks after cessation. This distinguishes drug-induced tinnitus from other forms of chronic tinnitus, which are typically permanent 3.

References

Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Research

Antidepressant therapy in tinnitus.

Hearing research, 2007

Research

Antidepressants for treatment of tinnitus.

Progress in brain research, 2007

Research

Clinical Practice Guideline: Tinnitus Update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.